Frank Moriarty
Impact in
- Geriatrics and Gerontology top 0.2%
- Pharmaceutical Practices and Patient Outcomes
- Family Practice top 0.5%
- Medication Adherence and Compliance
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 80
-
- Medication Adherence and Compliance 12
- Co-authors
- Tom FaheyKathleen BennettSusan M. SmithCaitríona CahirEmma WallaceRose Anne KennyColin HardyBarbara Clyne
- Journals
- Research in Social and Administrative Pharmacy (12 papers)BMJ Open (12 papers)British Journal of Clinical Pharmacology (10 papers)Age and Ageing (9 papers)European Journal of Clinical Pharmacology (4 papers)
- Partner nations
- IrelandUnited KingdomCanada
In The Last Decade
Frank Moriarty
131 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 150
- Geriatrics and Gerontology 1.1k
- Family Practice 313
- Applied Microbiology and Biotechnology 71
- Economics and Econometrics 702
- Toxicology 69
Countries citing papers authored by Frank Moriarty
This map shows the geographic impact of Frank Moriarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Moriarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Moriarty more than expected).
Fields of papers citing papers by Frank Moriarty
This network shows the impact of papers produced by Frank Moriarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Moriarty. The network helps show where Frank Moriarty may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frank Moriarty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 10 | |
| 13 | 2023 | 3 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 0 | |
| 17 | 2021 | 58 | |
| 18 | 2021 | 1 | |
| 19 | 2019 | 7 | |
| 20 | 2019 | 1 |
About Frank Moriarty
Frank Moriarty is a scholar working on Geriatrics and Gerontology, Family Practice, Toxicology, Economics and Econometrics and General Health Professions, having authored 157 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (80 papers), Health Systems, Economic Evaluations, Quality of Life (55 papers), Chronic Disease Management Strategies (21 papers), Healthcare cost, quality, practices (16 papers), Primary Care and Health Outcomes (13 papers), Medication Adherence and Compliance (12 papers), Emergency and Acute Care Studies (10 papers) and Pharmacovigilance and Adverse Drug Reactions (10 papers). The work is most often cited by research in Geriatrics and Gerontology (1.1k citations), Family Practice (313 citations), Applied Microbiology and Biotechnology (71 citations), Economics and Econometrics (702 citations) and Toxicology (69 citations). Frank Moriarty has collaborated with scholars based in Ireland, United Kingdom and Canada. Frequent co-authors include Tom Fahey, Kathleen Bennett, Susan M. Smith, Caitríona Cahir, Emma Wallace, Rose Anne Kenny, Colin Hardy, Barbara Clyne, Fiona Boland and Patrick Redmond. Their work appears in journals such as Research in Social and Administrative Pharmacy, BMJ Open, British Journal of Clinical Pharmacology, Age and Ageing and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.